Bisphosphocin Nu-3

DB16015InvestigationalSmall molecule

Bisphosphocin Nu-3 is under investigation in clinical trial NCT02737722 (Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus).

Formula / weight: C₁₈H₃₂N₂O₁₁P₂ · 514.405 g/mol (avg)
Also known as: Bisphosphocin Nu3 · Nu-3

Resolves to

Compound

UNII8BK3483OW5CAS403717-06-6ChEMBLCHEMBL4297360

Structure

InChIKeyZXQBUNYVGNOEBQ-ARFHVFGLSA-NSMILESCCCCOP(O)(=O)OC[C@H]1O[C@H](C[C@@H]1OP(O)(=O)OCCCC)N1C=C(C)C(=O)NC1=O

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Bisphosphocin Nu-3, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account